Compounds and methods for stabilizing thrombin activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10435681
APP PUB NO 20190017040A1
SERIAL NO

16144262

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to compounds useful in stabilizing thrombin activity, thrombin compositions comprising the compounds, methods of using the compounds and methods of identifying compounds capable of stabilizing thrombin activity. The compounds are preferably isolated peptides comprising or interacting with the gamma loop of thrombin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • OMRIX BIOPHARMACEUTICALS LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Doron, Sivan Moshav Arugot, IL 18 11
Orr, Nadav Mazkeret Batia, IL 19 6
Pilpel, Yair Rehovot, IL 15 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 8, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 8, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00